KEGG Pathways
370 pathways | Page 1 / 13
| Pathway ID | Pathway Name | Multi-Target Proteins | |
|---|---|---|---|
hsa01100 |
Metabolic pathways | 2140 | View |
hsa05200 |
Pathways in cancer | 763 | View |
hsa04740 |
Olfactory transduction | 687 | View |
hsa05022 |
Pathways of neurodegeneration - multiple diseases | 686 | View |
hsa05010 |
Alzheimer disease | 551 | View |
hsa04519 |
Cadherin signaling | 531 | View |
hsa04151 |
PI3K-Akt signaling pathway | 519 | View |
hsa05014 |
Amyotrophic lateral sclerosis | 514 | View |
hsa04080 |
Neuroactive ligand-receptor interaction | 496 | View |
hsa05165 |
Human papillomavirus infection | 469 | View |
hsa05016 |
Huntington disease | 427 | View |
hsa04010 |
MAPK signaling pathway | 413 | View |
hsa05020 |
Prion disease | 413 | View |
hsa04517 |
IgSF CAM signaling | 408 | View |
hsa04060 |
Cytokine-cytokine receptor interaction | 408 | View |
hsa05012 |
Parkinson disease | 392 | View |
hsa05166 |
Human T-cell leukemia virus 1 infection | 375 | View |
hsa04020 |
Calcium signaling pathway | 359 | View |
hsa04810 |
Regulation of actin cytoskeleton | 343 | View |
hsa05163 |
Human cytomegalovirus infection | 343 | View |
hsa04024 |
cAMP signaling pathway | 340 | View |
hsa05131 |
Shigellosis | 336 | View |
hsa05132 |
Salmonella infection | 335 | View |
hsa05169 |
Epstein-Barr virus infection | 335 | View |
hsa04144 |
Endocytosis | 334 | View |
hsa05208 |
Chemical carcinogenesis - reactive oxygen species | 328 | View |
hsa05417 |
Lipid and atherosclerosis | 328 | View |
hsa04014 |
Ras signaling pathway | 327 | View |
hsa04714 |
Thermogenesis | 325 | View |
hsa05171 |
Coronavirus disease - COVID-19 | 320 | View |